Company Information

    Seattle Genetics was founded on January 1998. The company is based in Bothell, WA, USA . The number of employees in Seattle Genetics is less than 1000. Seattle genetics is dedicated to improving patient outcomes with advanced antibody-drug conjugate technology.

    Here is how Seattle Genetics describes itself: "Seagen is dedicated to revolutionizing cancer care and improving patient outcomes with antibody–drug conjugate and small-molecule technologies."
      If you are the founder or part of the founding team, please tell the world your story

          Funding & investors

          Seattle Genetics has received 4 rounds of venture funding. The total funding amount is around $1739M. Last venture funding round was $1000M, announced on September, 2020.

            Similar Companies [beta]

              Venture Categories

                Active Venture Investors

                  Venture Competitors


                      Share:     facebook    twitter    linkedin    reddit    email

                        Ventures Media is one of the largest startup and venture capital communities for startup and venture capital funding information and analysis.

                        Leave a Reply

                        Your email address will not be published. Required fields are marked *